Journal of Pharmaceutical and Biomedical Analysis 2002-06-20

The isomeric metabolites of doxepin in equine serum and urine.

Heinz-Werner Hagedorn, Heribert Meiser, Heidrun Zankl, Rüdiger Schulz

Index: J. Pharm. Biomed. Anal. 29(1-2) , 317-23, (2002)

Full Text: HTML

Abstract

Due to its tranquilizing properties, the tricyclic antidepressant doxepin may be misused as a doping agent in competition horses. Therefore, efficient analytical procedures are required to detect this drug in samples submitted for doping control. To screen for parent doxepin in equine blood and urine, a less specific method has been accepted employing gas chromatography (GC) combined with electron impact (EI) mass spectrometry (MS). The aim of this study was identification of doxepin metabolites providing more specific MS data to verify positives resulting from screening. Thus, after a horse was given doxepin-HCl (1 mg/kg, i.v.), blood and urine were analyzed for free or conjugated metabolites using GC combined with EI- and positive chemical ionization (PCI) MS. In both of the sample materials, cis- and trans-isomers of desmethyldoxepin were detected for up to 48 h after treatment using trifluoracetylation and GC/EI-MS. Following enzymic hydrolysis of urine and propionylation of extracts, each four isomers of hydroxy desmethyldoxepin and hydroxydoxepin were recovered for up to 24 and 48 h, respectively. These compounds were characterized by their EI- and PCI-mass spectra. Although distinct positions of the hydroxyl groups could not be determined, the presence of each two cis/trans-isomeric pairs of differently monohydroxylated metabolites may be assumed. Results reported here suggest, that screening horses for parent doxepin should be completed by analysis of its major isomeric metabolites, desmethyldoxepin and hydroxydoxepin, providing MS data specific enough for confirmatory analysis.


Related Compounds

  • nordoxepin
  • desmethyldoxepin

Related Articles:

Determination of perhexiline and its metabolite hydroxyperhexiline in human plasma by liquid chromatography/tandem mass spectrometry.

2009-10-01

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 877(27) , 3025-30, (2009)]

Simultaneous determination of doxepin and nordoxepin in serum using high-performance liquid chromatography.

[J. Chromatogr. A. 419 , 445-51, (1987)]

Quantitative determination of E- and Z-doxepin and E- and Z-desmethyldoxepin by high-performance liquid chromatography.

1995-08-01

[Ther. Drug Monit. 17(4) , 371-6, (1995)]

Bioequivalence: issues and options.

1997-12-01

[J. Pharmacokinet. Biopharm. 25(6) , 743-52, (1997)]

Doxepin and nordoxepin concentrations in body fluids and tissues in doxepin associated deaths.

2009-09-10

[Forensic Sci. Int. 190(1-3) , 74-9, (2009)]

More Articles...